Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Mineralocorticoid receptor blockade for renoprotection.

Cha DR.

Kidney Res Clin Pract. 2018 Sep;37(3):183-184. doi: 10.23876/j.krcp.2018.37.3.183. Epub 2018 Sep 30. No abstract available.

2.

A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats.

Dorotea D, Kwon G, Lee JH, Saunders E, Bae YS, Moon SH, Lee SJ, Cha DR, Ha H.

Pharmacology. 2018;102(3-4):180-189. doi: 10.1159/000491398. Epub 2018 Aug 10.

PMID:
30099457
3.

Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice.

Dorotea D, Cho A, Lee G, Kwon G, Lee J, Sahu PK, Jeong LS, Cha DR, Ha H.

Exp Mol Med. 2018 Apr 20;50(4):38. doi: 10.1038/s12276-018-0053-x.

4.

Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78].

Cha RH, Kang SW, Park CW, Cha DR, Na KY, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS.

Kidney Res Clin Pract. 2018 Mar;37(1):98-99. doi: 10.23876/j.krcp.2018.37.1.98. Epub 2018 Mar 31.

5.

Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.

Baek SH, Cha RH, Kang SW, Park CW, Cha DR, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS, Na KY.

Korean J Intern Med. 2017 Nov 29. doi: 10.3904/kjim.2017.058. [Epub ahead of print]

6.

A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis.

Kwon G, Uddin MJ, Lee G, Jiang S, Cho A, Lee JH, Lee SR, Bae YS, Moon SH, Lee SJ, Cha DR, Ha H.

Oncotarget. 2017 Jun 16;8(43):74217-74232. doi: 10.18632/oncotarget.18540. eCollection 2017 Sep 26.

7.

Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.

Baek SH, Cha RH, Kang SW, Park CW, Cha DR, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS, Na KY.

Tohoku J Exp Med. 2017 Aug;242(4):281-290. doi: 10.1620/tjem.242.281.

8.

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.

Han SY, Yoon SA, Han BG, Kim SG, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang Y, Kim B, Shin S, Cha DR.

Diabetes Obes Metab. 2018 Feb;20(2):292-300. doi: 10.1111/dom.13059. Epub 2017 Sep 6.

PMID:
28719008
9.

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea.

Cha RH, Kang SW, Park CW, Cha DR, Na KY, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS.

Kidney Res Clin Pract. 2017 Mar;36(1):68-78. doi: 10.23876/j.krcp.2017.36.1.68. Epub 2017 Mar 31. Erratum in: Kidney Res Clin Pract. 2018 Mar;37(1):98-99.

10.

APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.

Cha JJ, Min HS, Kim KT, Kim JE, Ghee JY, Kim HW, Lee JE, Han JY, Lee G, Ha HJ, Bae YS, Lee SR, Moon SH, Lee SC, Kim G, Kang YS, Cha DR.

Lab Invest. 2017 Apr;97(4):419-431. doi: 10.1038/labinvest.2017.2. Epub 2017 Feb 6.

11.

Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).

Yoon SA, Han BG, Kim SG, Han SY, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang YH, Shin SH, Cha DR.

Diabetes Obes Metab. 2017 Apr;19(4):590-598. doi: 10.1111/dom.12863. Epub 2017 Feb 17.

PMID:
28019072
12.

Interleukin-6 signaling in podocyte hypertrophy.

Cha DR.

Kidney Res Clin Pract. 2016 Dec;35(4):195-196. Epub 2016 Oct 12. No abstract available.

13.

Long-term study of the association of adipokines and glucose variability with diabetic complications.

Cha JJ, Min HS, Kim K, Lee MJ, Lee MH, Kim JE, Song HK, Cha DR, Kang YS.

Korean J Intern Med. 2018 Mar;33(2):367-382. doi: 10.3904/kjim.2016.114. Epub 2016 Nov 4.

14.

Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines.

Noh JY, Song JY, Choi WS, Lee J, Seo YB, Kwon YJ, Ko GJ, Cha DR, Kang YS, Lee YK, Cheong HJ, Kim WJ.

Hum Vaccin Immunother. 2016 Nov;12(11):2902-2908.

15.

Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy.

Min HS, Cha JJ, Kim K, Kim JE, Ghee JY, Kim H, Lee JE, Han JY, Jeong LS, Cha DR, Kang YS.

J Korean Med Sci. 2016 Sep;31(9):1403-12. doi: 10.3346/jkms.2016.31.9.1403.

16.

Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study.

Lee SW, Kim S, Na KY, Cha RH, Kang SW, Park CW, Cha DR, Kim SG, Yoon SA, Han SY, Park JH, Chang JH, Lim CS, Kim YS.

PLoS One. 2016 Jun 1;11(6):e0156381. doi: 10.1371/journal.pone.0156381. eCollection 2016.

17.

Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice.

Kang YS, Lee MH, Song HK, Kim JE, Ghee JY, Cha JJ, Lee JE, Kim HW, Han JY, Cha DR.

Kidney Blood Press Res. 2016;41(3):311-24. doi: 10.1159/000443433. Epub 2016 May 25.

18.

A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Cha RH, Kang SW, Park CW, Cha DR, Na KY, Kim SG, Yoon SA, Han SY, Chang JH, Park SK, Lim CS, Kim YS.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):559-67. doi: 10.2215/CJN.12011214. Epub 2016 Feb 9.

19.

DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury.

Eun Lee J, Kim JE, Lee MH, Song HK, Ghee JY, Kang YS, Min HS, Kim HW, Cha JJ, Han JY, Han SY, Cha DR.

Lab Invest. 2016 May;96(5):547-60. doi: 10.1038/labinvest.2016.34. Epub 2016 Feb 15.

20.

A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus.

Kim K, Lee JH, Kim SC, Cha DR, Kang YS.

Kidney Res Clin Pract. 2014 Dec;33(4):229-33. doi: 10.1016/j.krcp.2014.09.001. Epub 2014 Nov 26.

21.

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction.

Min HS, Kim JE, Lee MH, Song HK, Kang YS, Lee MJ, Lee JE, Kim HW, Cha JJ, Chung YY, Hyun YY, Han JY, Cha DR.

Lab Invest. 2014 Jun;94(6):598-607. doi: 10.1038/labinvest.2014.50. Epub 2014 Mar 31.

22.

Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea.

Kim GH, Choi BS, Cha DR, Chee DH, Hwang E, Kim HW, Chang JH, Kim JK, Noh JW, Joo KW, Lee SC, Han SW, Kim S, Kim SW, Shin SK, Park W, Kim W, Huh W, Kwon YJ, Kang YS.

Kidney Res Clin Pract. 2014 Mar;33(1):52-7. doi: 10.1016/j.krcp.2013.12.003. Epub 2014 Feb 21.

23.

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet.

Min HS, Kim JE, Lee MH, Song HK, Lee MJ, Lee JE, Kim HW, Cha JJ, Hyun YY, Han JY, Cha DR, Kang YS.

Kidney Res Clin Pract. 2014 Mar;33(1):33-44. doi: 10.1016/j.krcp.2013.11.002. Epub 2014 Jan 11.

24.

Pseudomyxoma peritonei: a rare cause of oliguric acute kidney injury.

Min HS, Pyo JH, Moon ES, Choi J, Kang YS, Lee MJ, Cha JJ, Cha DR.

Chonnam Med J. 2013 Aug;49(2):87-90. doi: 10.4068/cmj.2013.49.2.87. Epub 2013 Aug 22.

25.

Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.

Kim HW, Lee JE, Cha JJ, Hyun YY, Kim JE, Lee MH, Song HK, Nam DH, Han JY, Han SY, Han KH, Kang YS, Cha DR.

Endocrinology. 2013 Sep;154(9):3366-76. doi: 10.1210/en.2012-2276. Epub 2013 Jul 3.

PMID:
23825123
26.

Glucocorticoids attenuate septic acute kidney injury.

Choi HM, Jo SK, Kim SH, Lee JW, Cho E, Hyun YY, Cha JJ, Kang YS, Cha DR, Cho WY, Kim HK.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):678-84. doi: 10.1016/j.bbrc.2013.05.042. Epub 2013 May 20.

PMID:
23702481
27.

Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.

Cha JJ, Kang YS, Hyun YY, Han SY, Jee YH, Han KH, Han JY, Cha DR.

Life Sci. 2013 Jun 21;92(23):1118-24. doi: 10.1016/j.lfs.2013.04.008. Epub 2013 Apr 30.

PMID:
23643633
28.

Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice.

Kim JE, Lee MH, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Han SY, Han KH, Han JY, Cha DR.

PLoS One. 2013 Apr 26;8(4):e62068. doi: 10.1371/journal.pone.0062068. Print 2013.

29.

Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice.

Cha JJ, Hyun YY, Lee MH, Kim JE, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Han JY, Cha DR.

Endocrinology. 2013 Jun;154(6):2144-55. doi: 10.1210/en.2012-2080. Epub 2013 Apr 8.

PMID:
23568555
30.
31.

Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.

Cha JJ, Hyun YY, Jee YH, Lee MJ, Han KH, Kang YS, Han SY, Cha DR.

Kidney Res Clin Pract. 2012 Sep;31(3):177-85. doi: 10.1016/j.krcp.2012.06.004. Epub 2012 Jun 26.

32.

Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy.

Hyun YY, Kim IO, Kim MH, Nam DH, Lee MH, Kim JE, Song HK, Cha JJ, Kang YS, Lee JE, Kim HW, Han JY, Cha DR.

Cell Transplant. 2012;21(11):2425-39. doi: 10.3727/096368912X639008. Epub 2012 Apr 17.

PMID:
22525004
33.

Recombinant fusion protein of albumin-retinol binding protein inactivates stellate cells.

Choi S, Park S, Kim S, Lim C, Kim J, Cha DR, Oh J.

Biochem Biophys Res Commun. 2012 Feb 3;418(1):191-7. doi: 10.1016/j.bbrc.2012.01.012. Epub 2012 Jan 12.

PMID:
22266308
34.

The role of visfatin in diabetic nephropathy.

Kang YS, Cha DR.

Chonnam Med J. 2011 Dec;47(3):139-43. doi: 10.4068/cmj.2011.47.3.139. Epub 2011 Dec 26.

35.

Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.

Nam DH, Lee MH, Kim JE, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Kim SH, Han SY, Han KH, Han JY, Cha DR.

Endocrinology. 2012 Mar;153(3):1387-96. doi: 10.1210/en.2011-1423. Epub 2012 Jan 10.

PMID:
22234468
36.

Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.

Kang YS, Cha JJ, Hyun YY, Cha DR.

Expert Opin Investig Drugs. 2011 Jun;20(6):745-56. doi: 10.1517/13543784.2011.575359. Epub 2011 Apr 6. Review.

PMID:
21466412
37.

Rapidly deteriorating parkinsonism and dysautonomia in patient with central pontine and extrapontine myelinolysis.

Kwon DY, Seo WK, Park MH, Kang YS, Koh SB, Cha DR, Park KW.

Clin Neurol Neurosurg. 2011 Jul;113(6):513-4. doi: 10.1016/j.clineuro.2011.02.002. Epub 2011 Feb 26. No abstract available.

PMID:
21353739
38.

Fatal PD peritonitis, necrotizing fasciitis, and bacteremia due to Shewanella putrefaciens.

Yim SY, Kang YS, Cha DR, Park DW, Youn YK, Jo YM, Kim JY, Song JY, Sohn JW, Cheong HJ, Kim WJ, Kim MJ, Choi WS.

Perit Dial Int. 2010 Nov-Dec;30(6):667-9. doi: 10.3747/pdi.2010.00084. No abstract available.

PMID:
21148067
39.

Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.

Kang YS, Lee MH, Song HK, Hyun YY, Cha JJ, Ko GJ, Kim SH, Lee JE, Han JY, Cha DR.

Nephrol Dial Transplant. 2011 Apr;26(4):1194-204. doi: 10.1093/ndt/gfq579. Epub 2010 Oct 4.

PMID:
20921292
40.

CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.

Kang YS, Lee MH, Song HK, Ko GJ, Kwon OS, Lim TK, Kim SH, Han SY, Han KH, Lee JE, Han JY, Kim HK, Cha DR.

Kidney Int. 2010 Nov;78(9):883-94. doi: 10.1038/ki.2010.263. Epub 2010 Aug 4.

41.

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.

Kang YS, Song HK, Lee MH, Ko GJ, Cha DR.

Diabetes Res Clin Pract. 2010 Aug;89(2):141-9. doi: 10.1016/j.diabres.2010.03.020. Epub 2010 Apr 20.

PMID:
20409603
42.

Visfatin is upregulated in type-2 diabetic rats and targets renal cells.

Kang YS, Song HK, Lee MH, Ko GJ, Han JY, Han SY, Han KH, Kim HK, Cha DR.

Kidney Int. 2010 Jul;78(2):170-81. doi: 10.1038/ki.2010.98. Epub 2010 Apr 14.

43.

PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.

Han JY, Kim YJ, Kim L, Choi SJ, Park IS, Kim JM, Chu YC, Cha DR.

J Korean Med Sci. 2010 Jan;25(1):35-41. doi: 10.3346/jkms.2010.25.1.35. Epub 2009 Dec 29.

44.

Aldosterone and diabetic kidney disease.

Kang YS, Cha DR.

Curr Diab Rep. 2009 Dec;9(6):453-9. Review.

PMID:
19954691
45.

Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy.

Han KH, Han SY, Kim HS, Kang YS, Cha DR.

Inflammation. 2010 Jun;33(3):137-43. doi: 10.1007/s10753-009-9167-6.

PMID:
19921414
46.

Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.

Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR.

Nephrology (Carlton). 2009 Oct;14(7):681-8. doi: 10.1111/j.1440-1797.2009.01085.x.

PMID:
19796028
47.

A rare case of perinephric urinoma due to idiopathic retroperitoneal fibrosis.

Cha JJ, Heo JY, Ko GJ, Cha DR, Kang YS.

NDT Plus. 2009 Apr;2(2):190-2. doi: 10.1093/ndtplus/sfp011. No abstract available.

48.

The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.

Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, Kim S, Jeon US, Do JY, Park JW, Yoon KW, Shin YT, Lee KW, Na KR, Cha DR, Kang YS; Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members.

J Korean Med Sci. 2009 Jan;24 Suppl:S30-7. doi: 10.3346/jkms.2009.24.S1.S30. Epub 2009 Jan 28.

49.

Quiz page. Final diagnosis unilateral urinary obstruction in a man with peripheral vascular disease.

Oh CR, Ko GJ, Kang YS, Cha DR.

Am J Kidney Dis. 2009 Feb;53(2):xxxv-xxxvii. doi: 10.1053/j.ajkd.2008.08.016. No abstract available.

PMID:
19166795
50.

Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.

Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR.

Nephrology (Carlton). 2008 Dec;13(6):492-9. doi: 10.1111/j.1440-1797.2008.01005.x. Epub 2008 Sep 1.

PMID:
18771471

Supplemental Content

Support Center